Dopamine D3 receptor is decreased and D2 receptor is elevated in the striatum of Parkinson's disease-Reference-Cited by-同舟云学术

Dopamine D3 receptor is decreased and D2 receptor is elevated in the striatum of Parkinson's disease

Published:1998-09 Issue:5 Volume:13 Page:788-797
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov Disord.

Author:

Ryoo Han L.,Pierrotti Dylan,Joyce Jeffrey N.

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Reference40 articles.

1. Molecular neurobiology of D1 and D2 dopamine receptors. In: ed. Neuroscience and Psychopharmacology: D1:D2 Dopamine Receptor Interactions. San Diego, CA: Academic Press, 1993: 1-21.

2. Linking the Family of D2 Receptors to Neuronal Circuits in Human Brain: Insights into Schizophrenia

3. Localization of dopamine D3 receptors to mesolimbic and D2 receptors to mesostriatal regions of human forebrain.

4. Mesolimbic Dopamine D3 Receptors and Use of Antipsychotics in Patients With Schizophrenia

5. Ropinirole for the treatment of early Parkinson's disease

Cited by 106 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neurobiological and Pharmacological Perspectives of D3 Receptors in Parkinson’s Disease;Biomolecules;2022-02-01

2. The Cyclic Nitroxide TEMPOL Ameliorates Oxidative Stress but Not Inflammation in a Cell Model of Parkinson’s Disease;Antioxidants;2022-01-28

3. Dopamine D3 receptor ligand suppresses the expression of levodopa-induced dyskinesia in nonhuman primate model of parkinson's disease;Experimental Neurology;2022-01

4. Dopamine D3 Receptor in Parkinson Disease: A Prognosis Biomarker and an Intervention Target;Therapeutic Applications of Dopamine D3 Receptor Function;2022

5. Dopamine D3 Receptor Ligand Suppresses the Expression of Levodopa-Induced Dyskinesia in Nonhuman Primate Model of Parkinson’s Disease;2021-08-11